Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Efficacy and safety of intravesical resiniferatoxin in detrusor instability and hyperreflexia

March 18, 2003

Bladder selectivity demonstrated in preclinical and clinical studies with YM-905

March 17, 2003

GSK celebrates the international launch of Avodart

March 17, 2003

Fesoterodine pharmacodynamics and pharmacokinetics after multiple oral doses in man

March 17, 2003

ML-04 shows efficacy in chronic prostatitis

March 17, 2003

Shire to develop extended-release trospium

March 14, 2003

Watson files Oxytrol MAA in Europe

March 14, 2003

Selective iNOS inhibitor GW-274150 ameliorates renal I/R damage

March 11, 2003

Avodart introduced in U.K.

March 11, 2003

Levitra approved in E.U.

March 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.